维普期刊资源整合服务平台（V6.5）

151篇 您的检索式：作者名="LM FABBRI"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	From COPD to chronic systemic inflam matorysyndrome? 显示文摘	LM FABBRI KF RABE	2007	The Lancet2007，9589，：	1
2	Complex chronic comorbidities of COPD显示文摘	Fabbri LM Luppi F Beghe B	2008	Eur Respir2008，31，01：	1
3	Global strategy for the diagnosis,management and prevention of COPD:2003update显示文摘	Fabbri LM Hurd SS GOLD Scientific Committee	2003	Eur Respir J2003，22，1：	1
4	Global strategy for the diagnosis,management and prevention of COPD:2003 updated(editoria1)显示文摘	Fabbri LM Hurd SS	2003	Eur Respir J2003，22，1：	1
5	Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstruction pulmonary disease显示文摘	Fabbri LM Romagnoli M Corbetta L	2003	Am J Respir Crit Care Med2003，168，：	1
6	Complex chronic co- morbidities of COPD 显示文摘	Fabbri LM Luppi F Beghe B	2008	Eur Respir J2008，31，：	1
7	Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease 显示文摘	Fabbri LM Romagnoli M Corbetta L et a l	2003	Am J Respir Crit Care Med2003，167，3：	1
8	From COPD to chronic systemic inflammatory syndrome显示文摘	Fabbri LM Rabe KF	2007	Lancet2007，370，：	1
9	Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease 显示文摘	Fabbri LM Romagnoli M Corbetta L	2003	Am J Respir Crit Care Med2003，167，3：	1
10	Complex chronic comorbidities of copd显示文摘	Fabbri LM Luppi F Beghe B	2008	Eur Respir J2008，31，1：	1
11	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators:two randomised clinical trials显示文摘	Fabbri LM Calverley PM Izquierdo-Alonso JL	2009	Lancet2009，374，9691：	1
12	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with lon- gacting bronchodilators : two randomised clinical trials 显示文摘	Fabbri LM Calverley PM Lzquierdo-Alonso JL	2009	Lancet2009，374，9691：	1
13	Global strategy for the diagnosis, management and prevention of COPD: 2003 update 显示文摘	Fabbri LM Hurd SS	2003	EurRespir J2003，22，：	1
14	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials显示文摘	Fabbri LM Calverley PM Izquierdo-Alonso JL	2009	Lancet2009，374，9691：	1
15	Long-term macrolide treatment for chronic respiratory disease显示文摘	Spagnolo P Fabbri LM Bush A	2013	Eur Respir J2013，42，：	1
16	Global strategy for the diagnosis,management and prevention of COPD:2003 update显示文摘	Fabbri LM Hurd SS	2003	Eur Respir J2003，22，：	1
17	From COPD to chronic systemic inflam- matory syndrome显示文摘	Fabbri LM Rabe KF	2007	Lancet2007，370，9589：	1
18	Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57显示文摘	Balboni A Baricordi OR Fabbri LM	1996	Eur Respir J1996，9，2：	1
19	Complex chronic eomorbidities of C OPD显示文摘	Fabbri LM Luppi F Beghe B	2008	Eur Respir J2008，31，1：	1
20	From COPD to chronic systemic in- flammatory syndrome? 显示文摘	Fabbri LM Rabe KF	2007	Lancet2007，370，9589：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示